The Food and Drug Administration has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients “as quickly as possible, as appropriate,” the agency said.
in Business
The Food and Drug Administration has been in “sustained and ongoing” discussions with Gilead Sciences to make antiviral drug remdesivir available to Covid-19 patients “as quickly as possible, as appropriate,” the agency said.

